Trials / Conditions / Stage III Small Intestinal Adenocarcinoma AJCC v8
Stage III Small Intestinal Adenocarcinoma AJCC v8
3 registered clinical trials studyying Stage III Small Intestinal Adenocarcinoma AJCC v8 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma NCT04111172 | Thomas Jefferson University | Phase 2 |
| Recruiting | Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers NCT04205968 | SWOG Cancer Research Network | Phase 2 |
| Completed | Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarc NCT01208103 | M.D. Anderson Cancer Center | Phase 2 |